Fig. 11From: Docking and dynamic simulation study of Crizotinib and Temozolomide drug with Glioblastoma and NSCLC target to identify better efficacy of the drug2D and 3D interaction images of drug Temozolomide at the binding sites of protein ALK (2XP2: RC (S1, P2)Back to article page